Invasive aspergillosis in a tertiary-care hospital in Thailand

Journal of the Medical Association of Thailand

Volumn 90, Issue 5, 2007, Pages 895-902

  Kiertiburanakul, Sasisopin ^a   Thibbadee, Chittima ^a   Santanirand, Pitak ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Aspergillosis; Aspergillus spp; Fungus; Thailand

Indexed keywords

AMPHOTERICIN B; ANTINEOPLASTIC AGENT; CORTICOSTEROID; ITRACONAZOLE;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BODY REGIONS; CANCER CHEMOTHERAPY; CAUSE OF DEATH; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; FEMALE; FUNGUS ISOLATION; HAZARD RATIO; HUMAN; LABORATORY; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; NEUTROPENIA; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; THAILAND; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; EARLY DIAGNOSIS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; ITRACONAZOLE; MALE; MIDDLE AGED; NEUTROPENIA; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; THAILAND; TREATMENT OUTCOME;

EID: 34249091023     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Herbrecht R, Natarajan-Ame S, Letscher-Bru V, Canuet M. Invasive pulmonary aspergillosis. Semin Respir Crit Care Med 2004; 25: 191-202.
2. Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest 2002; 121: 1988-99.
3. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-803.
4. Cornet M, Fleury L, Maslo C, Bernard JF, Brucker G. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J Hosp Infect 2002; 51: 288-96.
5. Herbrecht R, Moghaddam A, Mahmal L, Natarajan-Ame S, Fornecker LM, Letscher-Bru V. Invasive aspergillosis in the hematologic and immunologic patient: new findings and key questions in leukemia. Med Mycol 2005; 43(Suppl 1): S239-S242.
6. Kullberg BJ, Oude Lashof AM. Epidemiology of opportunistic invasive mycoses. Eur J Med Res 2002; 7: 183-91.
7. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358-66.
8. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996; 23: 608-15.
9. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996; 33: 23-32.
10. Randhawa HS. Respiratory and systemic mycoses: an overview. Indian J Chest Dis Allied Sci 2000; 42: 207-19.
11. Pongbhaesaj P, Dejthevaporn C, Tunlayadechanont S, Witoonpanich R, Sungkanuparph S, Vibhagool A. Aspergillosis of the central nervous system: a catastrophic opportunistic infection. Southeast Asian J Trop Med Public Health 2004; 35: 119-25.
12. Tangthangtham A, Subhannachart P, Tungsagunwattana S. Transthoracic aspiration cytology for the diagnosis of thoracic infection. J Med Assoc Thai 2001; 84: 688-92.
13. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
14. Singh N, Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant 2003; 22: 258-66.
15. Bowden R, Chandrasekar P, White MH, Li X, Pietrelli L, Gurwith M, et al. A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients. Clin Infect Dis 2002; 35: 359-66.
16. Leenders AC, Daenen S, Jansen RL, Hop WC, Lowenberg B, Wijermans PW, et al. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections. Br J Haematol 1998; 103: 205-12.
17. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004; 170: 621-5.
18. Greene R. The pulmonary aspergilloses: three distinct entities or a spectrum of disease. Radiology 1981; 140: 527-30.
19. Aquino SL, Kee ST, Warnock ML, Gamsu G. Pulmonary aspergillosis: imaging findings with pathologic correlation. AJR Am J Roentgenol 1994; 163: 811-5.
20. Kuhlman JE, Fishman EK, Burch PA, Karp JE, Zerhouni EA, Siegelman SS. CT of invasive pulmonary aspergillosis. AJR Am J Roentgenol 1988; 150: 1015-20.
21. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990; 12: 1147-201.
22. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175: 1459-66.
23. Mylonakis E, Barlam TF, Flanigan T, Rich JD. Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases. Chest 1998; 114: 251-62.
24. Shetty D, Giri N, Gonzalez CE, Pizzo PA, Walsh TJ. Invasive aspergillosis in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1997; 16: 216-21.
25. Ng TT, Robson GD, Denning DW. Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology 1994; 140(Pt 9): 2475-9.